JAK2 and gastric cancer: In advanced GC, interleukin(IL)-6 and IL8 released by mesenchymal stromal cells (MSCs) promote polarization of M2-type TAMs in TME via the JAK2/STAT3 signaling pathway, resulting in immunosuppressive TME55.